ESR1 and carcinoma: Triple-negative breast cancer (TNBC) is a highly malignant carcinoma with negative expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounting for 15–25% of all breast cancers [1].